Holen Sie sich die Stockscreener-App
3.44
0.00%
0.00
Handel nachbörslich:
3.39
-0.05
-1.45%
Schlusskurs vom Vortag:
$3.44
Offen:
$3.49
24-Stunden-Volumen:
40,290
Relative Volume:
0.21
Marktkapitalisierung:
$29.93M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.98M
KGV:
-0.2817
EPS:
-12.2116
Netto-Cashflow:
$-31.84M
1W Leistung:
-5.49%
1M Leistung:
-7.03%
6M Leistung:
-15.48%
1J Leistung:
+365.49%
1-Tages-Spanne:
$3.36
$3.49
1-Wochen-Bereich:
$3.36
$3.65
52-Wochen-Spanne:
$0.6311
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Firmenname
Briacell Therapeutics Corp
Sektor
Branche
Telefon
(604) 921-1810
Adresse
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
3.44 | 29.67M | 0 | -30.98M | -31.84M | -12.21 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-02-14 | Eingeleitet | H.C. Wainwright | Buy |
Briacell Therapeutics Corp Aktie (BCTX) Neueste Nachrichten
BriaCell Therapeutics Corp (TSX:BCT) Shares Decline as Biotech Uncertainty, Funding Risks and Clinical Execution Concerns Pressure Sentiment - kalkine.ca
Enterprise value to EBIT forward of BriaCell Therapeutics Corp. – BOATS:BCTXL - TradingView
Briacell Therapeutics Corp (BCTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BriaCell Therapeutics Corp. (BCTXZ) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Briacell Therapeutics Corp (BCTX) Stock News Today - TradingKey
BriaCell Receives FDA Clearance to Initiate Bria-PROS+ Clinical Study in Prostate Cancer - Investing News Network
BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer - The Manila Times
FDA clearance lets BriaCell test personalized prostate immunotherapy - Stock Titan
BriaCell Therapeutics (BCTX) Rises 3.86% to $3.5 as Immuno-Oncology Interest BuildsAnalyst Downgrade Signals - dars.gov.et
BriaCell Therapeutics Warrant (BCTXZ) Holds at $0.09 as Long-Dated Biotech Option Trades FlatUp Down Volume - dars.gov.et
BriaCell Therapeutics Corp Revenue Breakdown – TSX:BCT - TradingView
BriaCell Therapeutics Corp. Revenue Breakdown – BOATS:BCTXL - TradingView
Why Did BriaCell Therapeutics Corp. (TSX:BCT) Stock Fall 5.49% on 31 July 2026? - kalkine.ca
Briacell Therapeutics Corp (BCTX) Institutional Confidence - TradingKey
Briacell Therapeutics Corp (BCTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BCTX|Briacell Therapeutics Corp|Price:3.338|Chg%:-0.022 - TradingKey
Briacell Therapeutics Corp (BCTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Briacell Therapeutics Corp (BCTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Briacell Therapeutics Corp (BCTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BriaCell Therapeutics Market Sentiment - Benzinga España
Briacell Therapeutics Corp (BCTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Briacell Therapeutics Corp (BCTX) Income Statement - TradingKey
BCTX|Briacell Therapeutics Corp|Price:3.525|Chg%:-0.055 - TradingKey
Briacell Therapeutics Corp (BCTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TradingKey - TradingKey
BriaCell Therapeutics Corp. Revenue Breakdown – NASDAQ:BCTXL - TradingView
BriaCell Therapeutics Corp. Revenue Breakdown – NASDAQ:BCTXZ - TradingView
BriaCell Therapeutics Corp Revenue Breakdown – MUN:8BT - TradingView
BCTX|Briacell Therapeutics Corp|Price:3.580|Chg%:-0.140 - TradingKey
BriaCell Therapeutics Warrant (BCTXL) Holds Steady at $0.89 as Support and Resistance Levels Come into FocusHidden Order - dars.gov.et
Price to earnings forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Why Briacell Therapeutics Corp stock is sliding today - Wealth Awesome
What's Going On With Briacell Therapeutics Corp Stock Monday? - Wealth Awesome
BriaCell Therapeutics Warrants (BCTXZ) Spike 9.32% as Shares Test Key Support at $0.10Analyst Upgrade Stocks - dars.gov.et
Is CRA International’s New Bria-IMT Role Quietly Redefining Its Healthcare Moat and Pricing Power (CRAI)? - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
BriaCell (BCTX) Expands Phase 3 Study with New Clinical Site - GuruFocus
What Does BriaCell's Latest Offering Mean for Shareholders - Kavout | AI
Briacell Therapeutics Corp. - Menafn
Stocks in play: BriaCell Therapeutics Corp. - Barchart.com
BriaCell Therapeutics Corp. - Baystreet.ca
Why Briacell Therapeutics Corp stock is skyrocketing today - Wealth Awesome
BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer - marketscreener.com
BriaCell Opens First Canadian SiteSunnybrookfor Pivotal Phase 3 Trial in Metastatic Breast Cancer - The Manila Times
Stocks In Play - Baystreet.ca
BriaCell Taps FUJIFILM for Bria-IMT Manufacturing - Contract Pharma
BriaCell (BCTX) Partners with Fujifilm for Cell Therapy Manufact - GuruFocus
BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™ - The Manila Times
BriaCell Therapeutics Corp.: BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT - FinanzNachrichten.de
What's Going On With Briacell Therapeutics Corp Stock Tuesday? - Wealth Awesome
BriaCell Therapeutics Corp. Warrants (BCTXZ) Hold Steady at $0.1 Amid Quiet TradingTotal Put Call - dars.gov.et
Finanzdaten der Briacell Therapeutics Corp-Aktie (BCTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):